What is the half-life of Tirzepatide (GIP and GLP-1 receptor agonist)?
Vikas Patel, an emergency physician who co-founded a longevity clinic, put the same worry in cancer terms in that Nature feature: BPC-157 supposedly heals by spurring the growth of new blood vessels, and that could also promote tumour growth
A comprehensive medication review is critical to identify drugs that may contribute to blood pressure reduction, including antihypertensives, alpha-blockers, tricyclic antidepressants, and certain medications for benign prostatic hyperplasia
Both are driven by cytokines and complement originating from the retinal pigment epithelium (RPE)
This absence of formal research means that any combined use is based on extrapolation from individual drug studies, theoretical pharmacology, and anecdotal clinical experience rather than robust evidence
SUPPORTS YOUR GLP-1 JOURNEY If you're taking a GLP-1 medication, you know it can come with side effects like low energy and digestive discomfort